Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASML HOLDING NV (ASML)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

ASML reports transactions under its current share buyback program

Market reaction Comment Full text

COYA THERAPEUTICS, INC. (COYA)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease

Market reaction Comment Full text

MARINEMAX INC (HZO)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

MarineMax Expands Premium Portfolio with Exclusive Distribution of Newly Launched Ducari Yachts

Market reaction Comment Full text

ADVANCED FLOWER CAPITAL INC. (AFCG)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

AFC Announces Dividend for the Second Quarter 2026

Market reaction Comment Full text

TRADEWEB MARKETS INC. (TW)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Tradeweb Launches TARA, an AI-Powered Research Assistant for Institutional Credit Trading

Market reaction Comment Full text

SPYGLASS PHARMA, INC. (SGP)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

SpyGlass Pharma Appoints Shannon Treviño as General Counsel

Market reaction Comment Full text

APTIV PLC (APTV)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Aptiv Showcasing Next Generation Intelligent Edge Solutions at Automate 2026

Market reaction Comment Full text

HUMACYTE, INC. (HUMA)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting

Market reaction Comment Full text

LEGEND BIOTECH CORP (LEGN)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Market reaction Comment Full text

RECTITUDE HOLDINGS LTD. (RECT)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore

Market reaction Comment Full text
  • Previous
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next

Search

News categories

  • Technical Exchange News(13154)
  • Event(6229)
  • SEC News(330600)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184325)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin